Minimum size survival analysis sampling plans for comparing multiple treatment groups to a single control group

Communications in Statistics - Theory and Methods

Volumn 43, Issue 13, 2014, Pages 2689-2701

  Jeske, Daniel R ^a   Flegal, James M ^a   Spindler, Stephen R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Censored data; Family wise Type 1 error rate; Sample size; Survival analysis; Weibull distribution

Indexed keywords

BIOINFORMATICS; WEIBULL DISTRIBUTION;

CENSORED DATA; ERROR RATE; SAMPLE SIZES; SAMPLING PLANS; STUDY SCENARIOS; SURVIVAL ANALYSIS; SURVIVOR FUNCTION; TREATMENT GROUP;

SAMPLING;

EID: 84903121883     PISSN: 03610926     EISSN: 1532415X     Source Type: Journal    
DOI: 10.1080/03610926.2012.683125     Document Type: Article

References (26)

1. Ahnn, S., Anderson, S.J. (1995). Sample size determination for comparing more than two survival distributions. Statist. Med. 14: 2273-2282.
2. Ahnn, S., Anderson, S.J. (1998). Sample size determination in complex clinical trials comparing more than two groups for survival endpoints. Statist. Med. 17: 2525-2534.
3. Bernstein, D., Lagakos, S.W. (1978). Sample size and power determination for stratified clinical trials. J. Statist. Computat. Simul. 8: 65-73.
4. Breslow, N., Haug, C. (1972). Sequential comparison of exponential survival curves. J. Amer. Statist. Assoc. 67: 691-697.
5. Collett, D. (2003). Modeling Survival Data in Medical Research. London: Chapman and Hall.
6. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Amer. Statist. Assoc. 50: 1096-1121.
7. Finney, D.J. (1952). Statistical Methods in Biological Assay. New york: Hafner Publishing Company.
8. Fleiss, J.L. (1986). Design and Analysis of Clinical Experiments. New york: John Wiley & Sons, Inc.
9. Friedman, L.M., Furberg, C.D., Demets, D.L. (2010). Fundamentals of Clinical Trials. New York: Springer.
10. George, S.L., Desu, M.M. (1974). Planning the size and duration of a clinical trial studying the time to some critical event. J. Chron. Dis. 27: 15-24.
11. Halabi, S., Singh, B. (2004). Sample size determination for comparing several survival curves with unequal allocation. Statist. Med. 23: 1793-1815.
12. Heo, M., Faith, M.S., Allison, D.B. (1998). Power and sample size for survival analysis under the weibull distribution when the whole lifespan is of interest. Mechan. Ageing Develop. 102: 45-53.
13. Hinkley D.V. (1975). On power transformations to symmetry. Biometrika 62: 101-111.
14. Hosmer, D.W., Lemeshow, S. May, S. (2008). Applied Survival Analysis. New york: John Wiley & Sons.
15. Julious, S.A. (2010). Sample Sizes for Clinical Trials. New york: CRC Press.
16. Jung, S., Hui, S. (2002). Sample size calculation for rank tests comparing K survival distributions. Lifetime Data Anal. 8: 361-373.
17. Lawless, J.F. (1982). Statistical Models and Methods for Lifetime Data. New york: John Wiley & Sons.
18. Liu, P.Y., Dahlberg, S. (1995). Design and analysis of multiarm clinical trials with survival endpoints. Control. Clin. Trials 16: 119-130.
19. Liu, S., Tu, D. (2008). On the applications of Fisher's least significant difference (LSD) procedure in three-arm clinical trials with survivor endpoints. Drug Info. J. 42: 81-91.
20. Lustbader, E.D., Litwin, S. (1981). Design of censored survival studies. Biometrics 37: 697-704.
21. Marschner, I.C. (2007). Optimal design of clinical trials comparing several treatments with a control. Pharmaceut. Statist. 6: 23-33.
22. Makuch, R.W., Simon, R.M. (1982). Sample size requirements for comparing time-to-failure among k treatment groups. J. Chron. Dis. 35: 861-867.
23. Marschner, I.C. (2007). Optimal design of clinical trials comparing several treatments with a control. Pharmaceut. Statist. 6: 23-33.
24. Schoenfeld, D. (1981). The asymptotic properties of nonparametric tests for comparing survival distributions. Biometrika 68: 316-319.
25. Schoenfeld, D. (1983). Sample-size formula for the proportional-hazards regression model. Biometrics 39: 499-503.
26. Spindler, S.R., Mote, P.L. (2007). Screening candidate longevity therapeutics using gene-expression arrays. Gerontology 53: 306-321.